INDOSE Funding: How Much Did They Raise & Key Investors

How Much Did INDOSE Raise?
Funding & Key Investors

INDOSE has solidified its position in the consumer health technology sector by securing a total of $3.6M in cumulative capital. This trajectory of financial backing, which includes a recent $145K strategic investment, underscores the market's confidence in the company's proprietary hardware solutions. By prioritizing precision and real-time metering, the firm has successfully navigated the complexities of the vaporizer market, transitioning from early-stage venture support to more sophisticated debt financing structures.

The company's ability to attract significant investment reflects its operational maturity and the scalability of its core technology. As the regulatory and consumer landscapes for vaporized products continue to shift, INDOSE remains a focal point for institutional investors seeking exposure to high-growth, hardware-enabled health platforms.

What is INDOSE?

INDOSE

Manufacturing

Electronics

Medical Devices & Equipment

INDOSE is recognized as the developer of the world's first real-time, metered precise dosage vaporizer. Co-founded by tech entrepreneur Benzi Ronen alongside Ari and Dani Freeman, the company leverages a deep history of product development and retail distribution. By integrating advanced metering technology into a consumer-facing device, INDOSE addresses critical industry challenges regarding consistency and user safety. The company operates at the intersection of hardware innovation and wellness, positioning itself as a leader in the emerging category of precision-dosed delivery systems. Its market strategy focuses on delivering a standardized experience that appeals to both retail consumers and professional stakeholders, effectively bridging the gap between traditional vaporizer hardware and medical-grade precision.

How much funding has INDOSE raised?

INDOSE has raised a total of $3.6M across 2 funding rounds:

2019

Series A

$3.5M

2021

Debt

$145K

Series A (2019): $3.5M with participation from Casa Verde Capital

Debt (2021): $145K led by PPP

Key Investors in INDOSE

Casa Verde Capital

Casa Verde is a premier venture capital firm specializing exclusively in the cannabis industry, focusing on scalable, capital-efficient businesses led by world-class management teams.

PPP

Public-Private Partnership

What's next for INDOSE?

With the recent infusion of $145K, INDOSE is well-positioned to accelerate its product roadmap and expand its retail footprint. The strategic focus will likely shift toward scaling manufacturing capabilities and deepening its penetration into international markets where demand for metered-dosage technology is rising. As the company moves beyond its initial growth phase, the emphasis will remain on maintaining capital efficiency while navigating the evolving regulatory environment. Future milestones will likely involve the integration of data-driven insights from its user base to further refine its hardware offerings, ensuring that INDOSE remains at the forefront of the precision-delivery sector.

See full INDOSE company page

See More Financial Insights